APA (7th ed.) Citation

Palmer, S. C., Tendal, B., Mustafa, R. A., Vandvik, P. O., Li, S., Hao, Q., . . . Strippoli, G. F. M. (2021). Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: Systematic review and network meta-analysis of randomised controlled trials. BMJ (Online), 372, m4573. https://doi.org/10.1136/bmj.m4573

Chicago Style (17th ed.) Citation

Palmer, Suetonia C., et al. "Sodium-glucose Cotransporter Protein-2 (SGLT-2) Inhibitors and Glucagon-like Peptide-1 (GLP-1) Receptor Agonists for Type 2 Diabetes: Systematic Review and Network Meta-analysis of Randomised Controlled Trials." BMJ (Online) 372 (2021): m4573. https://doi.org/10.1136/bmj.m4573.

MLA (9th ed.) Citation

Palmer, Suetonia C., et al. "Sodium-glucose Cotransporter Protein-2 (SGLT-2) Inhibitors and Glucagon-like Peptide-1 (GLP-1) Receptor Agonists for Type 2 Diabetes: Systematic Review and Network Meta-analysis of Randomised Controlled Trials." BMJ (Online), vol. 372, 2021, p. m4573, https://doi.org/10.1136/bmj.m4573.